<SEC-DOCUMENT>0001178913-21-003411.txt : 20211108
<SEC-HEADER>0001178913-21-003411.hdr.sgml : 20211108
<ACCEPTANCE-DATETIME>20211108073543
ACCESSION NUMBER:		0001178913-21-003411
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20211108
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211108
DATE AS OF CHANGE:		20211108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		211386531

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cmmb="http://chemomab.com/20211108" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 7.7.0.0
         Copyright 1995 - 2021 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_c4648d413a80429490b83737684960a3" contextRef="c20211108to20211108" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_40a41d80193d454cbb0b921a064feef5" contextRef="c20211108to20211108">00-0000000</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_bb5eac91d82c47d694f161e9a8eda0ed" contextRef="c20211108to20211108">0001534248</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_8333d3990e9e481a8ccb6f0583db598e" contextRef="c20211108to20211108_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_af4ff742d27748fd8296f3a3aea54c8f" contextRef="c20211108to20211108_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cmmb-20211108.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20211108to20211108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-08</xbrli:startDate><xbrli:endDate>2021-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211108to20211108_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-08</xbrli:startDate><xbrli:endDate>2021-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211108to20211108_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534248</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-08</xbrli:startDate><xbrli:endDate>2021-11-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div> <br />
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b> UNITED STATES</b></p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>WASHINGTON, D.C. 20549</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;&#160;</p>
      <p style="font: 14pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_96b53ed8741f43b0a807addae24647f5" contextRef="c20211108to20211108">8-K</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>CURRENT REPORT</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Pursuant to Section&#160;13 or 15(d)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>of the Securities Exchange Act of 1934</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_0e894bbd55e1489eba1120aa38f50e1b" contextRef="c20211108to20211108" format="ixt:datemonthdayyearen">November 8, 2021</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
      <p style="font: 16pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_101822c259f8405ba948b1d5acff0439" contextRef="c20211108to20211108">Chemomab Therapeutics Ltd.</ix:nonNumeric><br />
        </b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>(Exact name of Registrant as Specified in Its Charter)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" id="z285fd0a939d14cb8a3bc8f7a71eaacd4" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">State of <ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_cea7ebe73da5489db00983dcb9d209ef" contextRef="c20211108to20211108" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric></td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_3255d63d9c0b4a8794333efd1e0520f2" contextRef="c20211108to20211108">001-38807</ix:nonNumeric><br />
            </td>

    <td style="width: 33%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_40a41d80193d454cbb0b921a064feef5">81-3676773</span><br />
            </td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(State or Other Jurisdiction</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(Commission</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>(IRS Employer</b></td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>of Incorporation)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>File Number)</b></td>

    <td style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 33%;"><b>Identification No.)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" id="z9722526ab6394c8b8f5e095e36f85e0b" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr>

    <td style="width: 50%; text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_4ece7007436841e09816e13bb9feb2b9" contextRef="c20211108to20211108">Kiryat Atidim, Building 7</ix:nonNumeric></span><br />
            </td>

    <td style="width: 50%; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_494e4143e55847d3abe3805475b61f6d" contextRef="c20211108to20211108">Tel Aviv</ix:nonNumeric>,
                <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_a56faf7a023a43a1ae7279d957270bc0" contextRef="c20211108to20211108" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_0760a372535c47a4b8564165d8129910" contextRef="c20211108to20211108">6158002</ix:nonNumeric><br />
              </b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Address of principal executive offices)</b></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 50%;"><b>(Zip Code)</b></td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric name="dei:CityAreaCode" id="Fact_b31a1775009940a484705583a8b3a2be" contextRef="c20211108to20211108">972</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_383b2e6f9e0b4fbcbea4e5d96f20bb14" contextRef="c20211108to20211108">77-331-0156</ix:nonNumeric></b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>(Former name or former address, if changed since last report)</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" id="z098c736b414e41d18fe04e045d32303b" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: top;">

    <td style="width: 5%; text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_2da81b2a38ff495d93bc173cbcca33a5" contextRef="c20211108to20211108" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: 95%; text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_adac142c6557414f939f3c55131c5c5b" contextRef="c20211108to20211108" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_c897035c84b54c51ab0ed9db5e9a9d7e" contextRef="c20211108to20211108" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">&#160;</td>

  </tr>

  <tr style="vertical-align: top;">

    <td style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_497cdf253aa6419c8c1b303a37236acc" contextRef="c20211108to20211108" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="text-align: justify; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px; text-align: center;"><b>Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <table cellspacing="0" cellpadding="0" border="0" id="z362a1c90af2f4d57a0bf9c1615787466" style="font: 10pt/normal Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; font-size-adjust: none; font-stretch: normal;">


  <tr style="vertical-align: bottom;">

    <td style="width: 49%; text-align: center; white-space: nowrap; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Title of each class</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 24%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Trading<br />
                Symbol(s)</b></td>

    <td style="width: 1%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 25%; text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);"><b>Name of each <br />
                exchange<br />
                on&#160;which&#160;registered</b></td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_e514741af9f242dd963e464bf4b8918e" contextRef="c20211108to20211108_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_d4e7c54ac4974820968e0e48224eca5a" contextRef="c20211108to20211108_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">CMMB</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_af4ff742d27748fd8296f3a3aea54c8f">Nasdaq Capital Market</span><br />
            </td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;">&#160;</td>

  </tr>

  <tr>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 49%; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_bb4b4dd6da104eb883791f1f5db1b96f" contextRef="c20211108to20211108_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">Ordinary shares, no par value per share</ix:nonNumeric><br />
            </td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 24%; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_773a3eea3d494583a0a4e79bfe2896ce" contextRef="c20211108to20211108_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">N/A</ix:nonNumeric></td>

    <td style="text-align: center; vertical-align: bottom; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 1%; font-weight: bold;">&#160;</td>

    <td style="text-align: center; vertical-align: top; font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 25%; font-weight: bold;"><span style="-sec-ix-hidden:Fact_8333d3990e9e481a8ccb6f0583db598e">Nasdaq Capital Market</span>*</td>

  </tr>


</table>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">* Not for trading; only in connection with the registration of American Depositary Shares.</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule&#160;12b-2 of the
        Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_abc54424917b434c9a2d5b951456189a" contextRef="c20211108to20211108" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">&#160;</p>
      <p style="font: 10pt 'Times New Roman',Times,serif; margin: 0pt 0px;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
        accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160; <ix:nonNumeric name="dei:EntityExTransitionPeriod" id="Fact_9d150cf0e8a0412d8f54d079b27ab0eb" contextRef="c20211108to20211108" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></p>
    </div>

    <div> <span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"><br />
      </span></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--PROfilePageNumberReset%Num%2%- % -%-->
    <div style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;">
      <div style="line-height: 1.25;">
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Item 5.02</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div>

        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">(b)</span>&#160;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Conclusion of Engagement with Outgoing Interim Chief Financial Officer</span></div>

        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On November 8, 2021, Chemomab Therapeutics Ltd. (the &#8220;Company&#8221;) and Ms. Sigal Fattal mutually agreed to conclude
          Ms. Fattal&#8217;s engagement as Interim Chief Financial Officer of the Company and its wholly-owned subsidiary Chemomab Ltd. (the &#8220;Subsidiary&#8221;). Ms. Fattal will continue to serve the Company and Subsidiary as a senior consultant to Mr. Marvin.</div>

        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">(c) Appointment of Chief Financial Officer and Chief Operating Officer</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On November 8, 2021, the Company issued a press release announcing that, on November 8, 2021, it appointed Mr.
          Donald Marvin as the Chief Financial Officer, Executive Vice President and Chief Operating Officer of the Company, effective as of November 8, 2021. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is
          incorporated herein by reference. The biographical information for Mr. Marvin appears below:</div>

        <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">Donald Marvin</span>,
          age 69, has more than 35 years of experience at growth enterprises in corporate finance and fundraising, strategy, corporate development, mergers and acquisitions, and operations.&#160; Mr. Marvin served as Executive Vice President and Chief Financial
          Officer of Lodo Therapeutics from 2020 until 2021. He was previously Chairman, President and CEO of Concentric from 2014 to 2021. Prior to his positions at Concentric, Mr. Marvin was Managing Partner of Cairn Associates from 2006 until 2014. He
          was President and CEO of IdentiGEN from 2006 until 2009. Mr. Marvin was a co-founder of Orchid BioSciences, where he served as Chief Operating Officer, CFO and Senior Vice President of Corporate Development from 1997 to 2003, and President and
          Chief Executive Officer of Diatron Corporation from 1986 until 1994. Earlier in his career, Mr. Marvin held positions of increasing responsibility at Abbott, Boehringer Ingelheim, Bayer, and PepsiCo. Mr. Marvin earned a Bachelor of Science degree
          from The Ohio State University and an MBA from Iona College.</div>

        <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div>

        <div style="text-align: justify; text-indent: 28.35pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mr. Marvin does not have a family relationship with any director or executive officer of the Company or person
          nominated or chosen by the Company to become a director or executive officer, and there are no arrangements or understandings between Mr. Marvin and any other person pursuant to which Mr. Marvin was selected to serve as Chief Financial Officer,
          Executive Vice President and Chief Operating Officer of the Company. There have been no transactions involving Mr. Marvin that would require disclosure under Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934, as amended, or
          the Exchange Act.</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-decoration: underline;">Employment Agreement and Other Compensatory Arrangements</span></div>

        <div style="line-height: 1.25;"><br />
        </div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On November 8, 2021, the Chemomab Therapeutics Inc., the Company's wholly owned subsidiary, entered into an
          Executive Employment Agreement with Mr. Marvin (the &#8220;Agreement&#8221;). Mr. Marvin will receive an annual base salary of $460,000, and will be part of the Company&#8217;s bonus program with a yearly bonus potential of 45% of his base annual base salary,
          which bonus will be based on the achievement of mutually agreeable objectives to be determined by Mr. Marvin and the Chief Executive Officer of the Company. Additionally, Mr. Marvin will receive (i) 1.5% of the outstanding equity of the Company,
          which exercise price is based on the average of Company&#8217;s ADS market value over the 30 calendar days preceding November 8, 2021, and vesting over four years, (ii) an additional 0.5% of the outstanding equity of the Company for the achievement of
          strategic goals as agreed upon with the Compensation Committee and approved by the Board of Directors, (iii) a $25,000 signing bonus, and (iv) a 12-month initial severance package, which will increase by one month every two years that Mr. Marvin
          is employed by the Company, provided however that such amount does not exceed 18 months.</div>

        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing description of the terms of the Agreement does not purport to be a complete description and is
          qualified in its entirety by reference to the Agreement, which is attached hereto as Exhibit 10.1 and is incorporated by reference in its entirety into this Item 5.02.</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 7.01 Regulation FD Disclosure.</div>

        <div style="line-height: 1.25;"><br />
        </div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: justify; text-indent: 27pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As described in Item 5.02 above, on November 8, 2021, the Company issued a&#160;press release&#160;announcing the
          appointment of Mr. Marvin as the Chief Financial Officer, Executive Vice President and Chief Operating Officer of the Company. A copy of the&#160;press release&#160;is furnished herewith as Exhibit 99.1 and incorporated herein by reference.</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01 Financial Statements and Exhibits.</div>

        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">(d) Exhibits</div>

        <div style="line-height: 1.25;"><br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z01fcca708a8444ec8e002e059da11971">


  <tr>

    <td style="width: 12.82%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit Number</div>
            </td>

    <td style="width: 87.18%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 12.82%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>

    <td style="width: 87.18%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">Press
                  release issued by Chemomab Therapeutics Ltd. dated November 8, 2021</a></div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div><br />
          </div>

          <div>
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">
                <table cellspacing="0" cellpadding="4" border="0" id="ze068fada1d374ba1bbf57d1f99238910" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 10pt;">


  <tr>

    <td style="border: 2px solid rgb(0, 0, 0); border-image: none; width: 13%; vertical-align: top;">
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Exhibit 104</div>
                      </td>

    <td style="width: 87%; vertical-align: top; border-top-color: rgb(0, 0, 0); border-right-color: rgb(0, 0, 0); border-bottom-color: rgb(0, 0, 0); border-top-width: 2px; border-right-width: 2px; border-bottom-width: 2px; border-top-style: solid; border-right-style: solid; border-bottom-style: solid;">
                        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</div>
                      </td>

  </tr>


</table>
              </div>

            </div>

          </div>

        </div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br />
        </div>

        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br />
        </div>

        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div style="text-align: center;"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">- 2 -</span></div>

          <div style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

        </div>

      </div>

      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br />
        </div>

        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
          behalf by the undersigned hereunto duly authorized.</div>

        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z79ba297e5dab4d0aadf484871e8e3ebc">


  <tr>

    <td style="width: 48.78%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td colspan="2" style="width: 37.76%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CHEMOMAB THERAPEUTICS LTD.</div>
            </td>

    <td style="width: 13.46%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48.78%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.76%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 34%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 13.46%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48.78%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: November 8, 2021</div>
            </td>

    <td style="width: 3.76%; vertical-align: top;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">By:</div>
            </td>

    <td style="width: 34%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/s/&#160;Dale Pfost</div>
            </td>

    <td style="width: 13.46%; vertical-align: middle;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48.78%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.76%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 34%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name: Dale Pfost</div>
            </td>

    <td style="width: 13.46%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>

  <tr>

    <td style="width: 48.78%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 3.76%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

    <td style="width: 34%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title: Chief Executive Officer</div>
            </td>

    <td style="width: 13.46%; vertical-align: bottom;">
              <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
            </td>

  </tr>


</table>
      <div style="line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

      </div>

      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">- 3 -</div>

      </div>

    </div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /><span style="font-family: 'Times New Roman',Times,serif; font-size: 10pt;"></span></div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using EDGARfilings PROfile 7.7.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="text-align: left; line-height: 1.25;">
        <div style="text-align: right;">
          <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
        </div>
        <img width="259" height="73" src="image00001.jpg"></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Chemomab Therapeutics Names Donald R. Marvin Chief Financial Officer, </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Executive Vice President and Chief Operating Officer</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-style: italic;">Seasoned veteran brings Chemomab three decades of diverse life sciences industry experience</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">TEL AVIV, Israel, November 8, 2021 </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-- </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Chemomab Therapeutics Ltd</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">. (</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Nasdaq: CMMB), </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(Chemomab) </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, today announced
        that Donald R. Marvin has been named Chief Financial Officer, Executive Vice President and Chief Operating Officer. Mr. Marvin is a seasoned biotechnology executive with over 35 years of experience at growth enterprises in corporate finance and
        fundraising, strategy, corporate development, mergers and acquisitions, and operations.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;Don&#8217;s deep expertise in building life sciences companies through a combination of organic growth and targeted strategic acquisitions will
      be invaluable as we advance our promising clinical programs and leverage the scientific foundation established by our founding team,&#8221; said Dale Pfost, PhD, Chief Executive Officer of Chemomab. &#8220;Don and I have worked separately and together to
      leverage innovative science, operational excellence and value-enhancing transactions to grow successful enterprises and create stakeholder value. I look forward to Don&#8217;s many contributions to Chemomab&#8217;s emerging leadership in developing novel
      therapeutics for fibrotic and inflammatory diseases with high unmet need.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Until its acquisition earlier this year, Mr. Marvin served as Executive Vice President and Chief Financial Officer of Lodo Therapeutics. He
      was previously Chairman, President and CEO of Concentric, an agtech company that develops biological and essential plant nutrient inputs. Before Concentric, he was President and CEO of IdentiGEN, a leading provider of DNA-based solutions to the
      agriculture and food industries. Mr. Marvin was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA testing, where he served as Chief Operating Officer, CFO and Senior Vice President of Corporate Development. A former New Jersey
      CFO of the Year, he has raised close to a half billion dollars in financings and has completed over a dozen successful mergers and acquisitions. Earlier in his career, Mr. Marvin held positions of increasing responsibility at Abbott, Boehringer
      Ingelheim, Bayer and PepsiCo. He has served on public and private company boards and regularly contributes columns to Forbes. Mr. Marvin earned a Bachelor of Science degree from The Ohio State University and an MBA from Iona College.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mr. Marvin noted, &#8220;I am delighted to join Chemomab and reunite with Dale at a young company with so much promise. Chemomab has identified a
      unique immunotherapy target with the potential to generate a pipeline in a product, which I see as a solid base for building a world-class company. First and foremost, we will strive to continue to make the most of our current clinical trials, which
      reflect Chemomab&#8217;s 10-year commitment to discipline, drive and excellence in its scientific development activities.&#160;I also look forward to working with Chemomab&#8217;s strong executive team and its talented scientists to extend the company&#8217;s capabilities
      and take us to the next stage.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Sigal Fattal, Chemomab&#8217;s interim CFO, will serve as a senior financial advisor to Mr. Marvin. Adi Mor, PhD, co-founder and CSO of Chemomab,
      commented, &#8220;We are delighted to have an executive with Don&#8217;s exceptional breadth of experience and established industry contacts join Chemomab. We also want to thank Sigal for her excellent work in building our finance organization and steering us
      through the transition to becoming a public company. We are very pleased that she will continue as a valued member of our senior team.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">About Chemomab Therapeutics Ltd.</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chemomab<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> is a clinical-stage biotech company focusing on the
          discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need. Based on the unique and pivotal role of the soluble protein </font>CCL24<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> in promoting fibrosis and inflammation, Chemomab developed </font>CM-101<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, a monoclonal antibody designed to bind and block CCL24 activity.
          CM-101 has demonstrated potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is currently in</font> Phase 2 safety and efficacy trials in patients with primary sclerosing cholangitis (PSC) and liver
        fibrosis, with a third Phase 2 trial in systemic sclerosis (SSc) expected to begin early in 2022.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For more information on Chemomab, visit <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>www.chemomab.com</u></font>.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Forward Looking Statements</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These
        forward-looking statements include, among other things, statements regarding the clinical development pathway for CM-101; the future operations of Chemomab and its ability to successfully initiate and complete clinical trials and achieve regulatory
        milestones; the nature, strategy and focus of Chemomab; the development and commercial potential and potential benefits of any product candidates of Chemomab; and that the product candidates have the potential to address high unmet needs of
        patients with serious fibrosis-related diseases and conditions. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based
        upon Chemomab&#8217;s current expectations. Forward-looking statements involve risks and uncertainties. Because such statements deal with future events and are based on Chemomab&#8217;s current expectations, they are subject to various risks and uncertainties
        and actual results, performance or achievements of Chemomab could differ materially from those described in or implied by the statements in this presentation, including: the uncertain and time-consuming regulatory approval process; risks related to
        Chemomab&#8217;s ability to correctly manage its operating expenses and its expenses; Chemomab&#8217;s plans to develop and commercialize its product candidates, focusing on&#160; CM-101; the timing of initiation of Chemomab&#8217;s planned clinical trials; the timing of
        the availability of data from Chemomab&#8217;s clinical trials; the timing of any planned investigational new drug application or new drug application; Chemomab&#8217;s plans to research, develop and commercialize its current and future product candidates; the
        clinical utility, potential benefits and market acceptance of Chemomab&#8217;s product candidates; Chemomab&#8217;s commercialization, marketing and manufacturing capabilities and strategy; Chemomab&#8217;s ability to protect its intellectual property position; and
        the requirement for additional capital to continue to advance these product candidates, which may not be available on favorable terms or at all. Additional risks and uncertainties relating to Chemomab&#8217;s and its business can be found under the
        caption &#8220;Risk Factors&#8221; and elsewhere in Chemomab&#8217;s filings and reports with the SEC. Chemomab expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to
        reflect any change in Chemomab&#8217;s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Contacts:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Investor Relations:</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
        </font>Irina Koffler<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
        </font>LifeSci Advisors, LLC<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
        </font>Phone: +1-917-734-7387<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
        </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>ir@chemomab.com</u></font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Media:</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Barbara Lindheim</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">BLL Partners for Chemomab</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Phone: +1-917-355-9234</div>
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>blindheim@bllbiopartners.com</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cmmb-20211108.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.6.0.0 Broadridge-->
<xs:schema targetNamespace="http://chemomab.com/20211108" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cmmb="http://chemomab.com/20211108" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20211108_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20211108_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cmmb-20211108_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://chemomab.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OrdinarySharesNoParValuePerShareMember" id="cmmb_OrdinarySharesNoParValuePerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cmmb-20211108_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.6.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20211108.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="definition: EntityListingsLineItems to EntityExTransitionPeriod" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="29.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="30.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20211108.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20211108.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="definition: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cmmb-20211108_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.6.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:label xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US" id="dei_EntityExTransitionPeriod_lbl">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:title="label: EntityExTransitionPeriod to dei_EntityExTransitionPeriod_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20211108.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember to cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20211108.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:label xlink:type="resource" xlink:label="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xml:lang="en-US" id="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1">Ordinary shares, no par value per share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrdinarySharesNoParValuePerShareMember" xlink:to="cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" xlink:title="label: OrdinarySharesNoParValuePerShareMember to cmmb_OrdinarySharesNoParValuePerShareMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cmmb-20211108_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 7.6.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://chemomab.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cmmb-20211108.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://chemomab.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20211108.xsd#cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:label="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="cmmb-20211108.xsd#cmmb_OrdinarySharesNoParValuePerShareMember" xlink:label="OrdinarySharesNoParValuePerShareMember" xlink:title="OrdinarySharesNoParValuePerShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesNoParValuePerShareMember" xlink:title="presentation: ClassOfStockDomain to OrdinarySharesNoParValuePerShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="EntityExTransitionPeriod" xlink:title="EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityExTransitionPeriod" xlink:title="presentation: EntityListingsLineItems to EntityExTransitionPeriod" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #M T8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ[GV ->J:7^SY8K&IU?6[B60]5M$5 /Q;=G\A78UAJ.CW^\Q3JSV/-Q\5O'
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MO^PG)_Z*BKU6O*O@#_R(E]_V$Y/_ $5%7JM<^(_BR-*?P(*RO$__ "*>L_\
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M_$'C &"YF6VL,Y%I;Y"G_>/5OQX]A6M\-OAQ/XB=]9U.%DT>W5F0.,?:7 X
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M)Y);MIPT.< %$7'('/RFNRHHJ92<I<S&DDK(*I:O9OJ.BW]C&RJ]S;R0JS=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \]\4^ 7FFDOM&
M5=SG=);$XY]5/]/_ -5>?7-K<6<QAN8)(9!U612I_6OH.HY8(ITV31)(OHZ@
MC]:]C"YQ4I1Y*BYE^)C.BF[H^>JWM%\(ZKK4BE(6@MCUGE&!CV'5OPKV*+3K
M&!]\-E;QL/XDB4']!5FMJN>2:M3C9^9*PZZLSM%T6TT*P6TM%.,Y=V^\[>IK
M1HHKPYSE.3E)W;-TK*R"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6UC:QVMI!%!;Q#:D42!54>P'2NBMC%*/+#J9PHM.[)J***\XZ0HHHH ****
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'HHHK(H__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>form8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cmmb="http://chemomab.com/20211108"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cmmb-20211108.xsd" xlink:type="simple"/>
    <context id="c20211108to20211108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
        </entity>
        <period>
            <startDate>2021-11-08</startDate>
            <endDate>2021-11-08</endDate>
        </period>
    </context>
    <context id="c20211108to20211108_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-08</startDate>
            <endDate>2021-11-08</endDate>
        </period>
    </context>
    <context id="c20211108to20211108_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534248</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cmmb:OrdinarySharesNoParValuePerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-08</startDate>
            <endDate>2021-11-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20211108to20211108"
      id="Fact_c4648d413a80429490b83737684960a3">false</dei:AmendmentFlag>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20211108to20211108"
      id="Fact_40a41d80193d454cbb0b921a064feef5">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="c20211108to20211108"
      id="Fact_bb5eac91d82c47d694f161e9a8eda0ed">0001534248</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20211108to20211108_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_8333d3990e9e481a8ccb6f0583db598e">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20211108to20211108_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_af4ff742d27748fd8296f3a3aea54c8f">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20211108to20211108"
      id="Fact_96b53ed8741f43b0a807addae24647f5">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20211108to20211108"
      id="Fact_0e894bbd55e1489eba1120aa38f50e1b">2021-11-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20211108to20211108"
      id="Fact_101822c259f8405ba948b1d5acff0439">Chemomab Therapeutics Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20211108to20211108"
      id="Fact_cea7ebe73da5489db00983dcb9d209ef">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20211108to20211108"
      id="Fact_3255d63d9c0b4a8794333efd1e0520f2">001-38807</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20211108to20211108"
      id="Fact_4ece7007436841e09816e13bb9feb2b9">Kiryat Atidim, Building 7</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20211108to20211108"
      id="Fact_494e4143e55847d3abe3805475b61f6d">Tel Aviv</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20211108to20211108"
      id="Fact_a56faf7a023a43a1ae7279d957270bc0">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20211108to20211108"
      id="Fact_0760a372535c47a4b8564165d8129910">6158002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20211108to20211108"
      id="Fact_b31a1775009940a484705583a8b3a2be">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20211108to20211108"
      id="Fact_383b2e6f9e0b4fbcbea4e5d96f20bb14">77-331-0156</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20211108to20211108"
      id="Fact_2da81b2a38ff495d93bc173cbcca33a5">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20211108to20211108"
      id="Fact_adac142c6557414f939f3c55131c5c5b">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20211108to20211108"
      id="Fact_c897035c84b54c51ab0ed9db5e9a9d7e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20211108to20211108"
      id="Fact_497cdf253aa6419c8c1b303a37236acc">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20211108to20211108_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_e514741af9f242dd963e464bf4b8918e">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20211108to20211108_StatementClassOfStockAxis_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember"
      id="Fact_d4e7c54ac4974820968e0e48224eca5a">CMMB</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20211108to20211108_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_bb4b4dd6da104eb883791f1f5db1b96f">Ordinary shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20211108to20211108_StatementClassOfStockAxis_OrdinarySharesNoParValuePerShareMember"
      id="Fact_773a3eea3d494583a0a4e79bfe2896ce">N/A</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20211108to20211108"
      id="Fact_abc54424917b434c9a2d5b951456189a">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="c20211108to20211108"
      id="Fact_9d150cf0e8a0412d8f54d079b27ab0eb">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139738432996296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  08,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Chemomab Therapeutics Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Kiryat Atidim, Building 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tel Aviv<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">6158002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">77-331-0156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember', window );">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMMB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember', window );">Ordinary shares, no par value per share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, no par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cmmb_OrdinarySharesNoParValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( '0\:%,'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !T/&A3N/1YD.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>*$[8*";-I66G#08K;.QF;+4UC6-C:R1]^SE>FS*V!]C1TN]/
MGT"M\D*Y@"_!>0QD,-Y-MA^B4'[-CD1> $1U1"MCF1)#:NY=L)+2,QS 2W62
M!X2ZJA[ (DDM2<(,+/Q"9%VKE5 !);EPP6NUX/UGZ#-,*\ >+0X4@9<<6#=/
M].>I;^$&F&&$P<;O NJ%F*M_8G,'V"4Y1;.DQG$LQR;GT@X<WI^?7O.ZA1DB
MR4%A^A6-H+/'-;M.?FLVV]TCZ^JJY@7G1;7:\5HT]Z)9?<RN/_QNPM9ILS?_
MV/@JV+7PZRZZ+U!+ P04    " !T/&A3F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M '0\:%-6FAV)TP0  .44   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9A=<^(V%(:OM[]"P]7N#,2V@$!V"#.$)"T3DM! NS/=Z86P!=:L;;F2',*_
M[Y%Q[+0UQV2FR47PA_3ZT='Q>R2/=E+]T"'GAKS$4:(O6Z$QZ5?'T7[(8Z;/
M9,H3N+.1*F8&3M76T:GB+,@[Q9%#7??<B9E(6N-1?FVAQB.9F4@D?*&(SN*8
MJ?T5C^3NLN6U7B\\B6UH[ 5G/$K9EB^Y^2U=*#AS2I5 Q#S10B9$\<UE:^)]
MO>I2VR%O\;O@._WFF-BAK*7\84]FP67+M40\XKZQ$@Q^GOF41Y%5 HZ_"M%6
M^4S;\>WQJ_IM/G@8S)II/I71-Q&8\+(U;)& ;U@6F2>Y^X47 ^I;/5]&.O]/
M=D5;MT7\3!L9%YV!(!;)X9>]%($XI0,M.N2!< X/RBFOF6'CD9([HFQK4+,'
M^5#SW@ G$CLK2Z/@KH!^9GPM_0R"; A+ G*3&&'V9)8<9ANB-G(,/,0V=?Q"
M\.H@2(\(/LCG,^(.VX2ZU/MG=P?82D!: M)<KWM$KV":"VU$LM7D^QP:D)GA
ML?X3D>^6\MU<OM<T_M4^Y76CQ;L/.W<(1*^$Z*$J$R (<HK;B&WK*/#^&Q9I
MCG#T2X[^:<%8<"6DS8> 0%;5Q@57RK-@V/[ITZ>&-#@OT<Y1P2(-GO@6$D$Q
M8'Q@<2T8KC,%5Y,Q6Y-5R!5+>6:$K\G<!&<(Y*"$')P".4M\J5*I\C>H398&
M0DBD(E.9)4;MX3>H)<?%YUV$<%@2#D\AO!41)P]9O.:J#@37<%VOTQT.W0'"
M<U'R7)S"LV(O9!9 YHF-\/.P(72XHNMVW,,?@N>YE3VZIP!.@D!QK=NO!R1W
MH<>D=AX;).^$VC-#)D9 ?6N3JTQ$ 5@;P>+IO?%S[UW 4WL&R;>2NWHWQ^56
M/"*39_&,L556[M'WL1U>B%HL7&DVQX J\_=P^_XWT$)JPR+RATB/OJ0-BN=>
M?^BZ%*.KJH*'VWH^=1-8:QV'P04N!BA(518\W,WGTH>H+$*98*[1(#(8=+I=
MK^-Z_7,,JBH('N[DWY0PAB<0FSC.DL(V="T8+M14/;W*_CW<HI<R$KZPZQ1R
M#YZO!(MJ>7"51I[*[#W<J1>*=WP(#T]\?ECDP#J#*_*XV1R90EROD:RR?0]W
MZ?^0S;3.@*P1$)=M J25[].3?/\FYFIKY_-G4#"A3;:4);6.U2!H5(:2509/
M3S+XFQ>R@G60%GFU/"S8:K%PM<:(O5FGGV3N4YA-!6XQ@XE\(7>\/E:X%!1O
MK]_MT=X0(ZM<GN*>#,MK!?Z0D&N>2@@8[#[),F1@^6W"F1_"[A)VM-HN/V"F
MS0X.]N0S=;] W83*;)OKHGDB2<H4>691QDD*F9K?(-_ON75%;$-"*]NGO8_8
M\=#*SBGNQ"MA8/DG-\2CG]=?R)+[&7AI_43A2A\>66R\5:6@N,'#>Y(OL);[
M>"UK';E!8'I_?X615 6"-A2((M3P]OHA2[;\Z"ZF0>AALKR>_(HQ546"XJ;^
M^#_F>.7_].)#=O65?W=QNWU'CC<HG1@?C+KR]F[#:KLQ4QL$'IP)!E*9>1=W
MX-,3M4'H>*(Z;SY:V0^ ]\Q66DTBO@$E]VP UJ,.W]0.)T:F^7>LM31&QOEA
MR!DL%VP#N+^1TKR>V$]CY9?-\=]02P,$%     @ =#QH4Y^@&_"Q @  X@P
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ =#QH4P=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" !T/&A3N/1YD.X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " !T/&A3F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( '0\:%-6
MFAV)TP0  .44   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " !T/&A3GZ ;\+$"  #B#   #0
M    @ $6#0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( '0\:%.7BKL<P
M !,"   +              "  ?(/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M '0\:%,<.&7J/P$  #P"   /              "  =L0  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " !T/&A3)!Z;HJT   #X 0  &@
M@ %'$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !T
M/&A399!YDAD!  #/ P  $P              @ $L$P  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  !V%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://chemomab.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8k.htm">form8k.htm</File>
    <File>cmmb-20211108.xsd</File>
    <File>cmmb-20211108_def.xml</File>
    <File>cmmb-20211108_lab.xml</File>
    <File>cmmb-20211108_pre.xml</File>
    <File>exhibit_99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "cmmb-20211108_def.xml"
     ]
    },
    "inline": {
     "local": [
      "form8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cmmb-20211108_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmmb-20211108_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cmmb-20211108.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 36,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "cmmb",
   "nsuri": "http://chemomab.com/20211108",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20211108to20211108",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://chemomab.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "form8k.htm",
      "contextRef": "c20211108to20211108",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "cmmb_AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20211108",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "cmmb_OrdinarySharesNoParValuePerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, no par value per share [Member]"
       }
      }
     },
     "localname": "OrdinarySharesNoParValuePerShareMember",
     "nsuri": "http://chemomab.com/20211108",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityListingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Listings [Line Items]"
       }
      }
     },
     "localname": "EntityListingsLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityListingsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container for exchange listing information for an entity",
        "label": "Entity Listings [Table]"
       }
      }
     },
     "localname": "EntityListingsTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://chemomab.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001178913-21-003411-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-21-003411-xbrl.zip
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M]+VKJ;4-^=[E++,2QRW,<J&;^H-^Q#0@\YMHWOS U:Y<#?XY\6@+J.B=U;^
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MYXSR@FLSG.L=5"-=S=-8SP3=HQU:3Y!WP]3;B"^DP,QKGNU1O_T1B&OV6=A
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M.&LN:'1M[3UK<]LXDM^OZOX#UKO9<?8LB4^1=!Q7*;*3\4W\.-NS.[5?ID
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M+\;LADLZ\'>U/8+_O57D>(W7YE6$+QL2AK>;UO6_EVNQB?"D@KJJ4WC4QEG
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MS*^W?,XU_WW0\1,^/<0?PWP4P8__!U!+ 0(4 Q0    ( '0\:%,,1=GY]0,
M ( 2   1              "  0    !C;6UB+3(P,C$Q,3 X+GAS9%!+ 0(4
M Q0    ( '0\:%.TAC6O-P<  .I'   5              "  20$  !C;6UB
M+3(P,C$Q,3 X7V1E9BYX;6Q02P$"% ,4    " !T/&A3ZXO6-I<*  #\;P
M%0              @ &."P  8VUM8BTR,#(Q,3$P.%]L86(N>&UL4$L! A0#
M%     @ =#QH4Y0M@^M !P  J%   !4              ( !6!8  &-M;6(M
M,C R,3$Q,#A?<')E+GAM;%!+ 0(4 Q0    ( '0\:%.1A9%.(!   /<Z   0
M              "  <L=  !E>&AI8FET7SDY+3$N:'1M4$L! A0#%     @
M=#QH4PNRT8\P'   7ZT   H              ( !&2X  &9O<FTX:RYH=&U0
52P4&      8 !@!^ 0  <4H

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
